IMBiologics
Business Services · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
광교 센트럴비 260 즈타워 11층, 수원시, 경기도, South Kor...Website
www.imbiologics.comRevenue
<$5 MillionIndustry
About IMBiologics
IMBiologics is an innovative biopharmaceutical company established in August 2020, specializing in the development of antibody-based therapeutics for autoimmune diseases and immuno-oncology. Utilizing their proprietary antibody modality technology, IM-OpDECon, the company aims to address unmet medical needs in the field of immunomodulatory biologics. With a vision to launch global blockbuster drugs, IMBiologics aspires to become a leading biotech firm capable of developing and obtaining approvals for innovative medicines. The company is focused on expanding its pipeline through advanced antibody design and optimization techniques.Explore more
SIC Code 87,873NAICS Code 54,541Show more
IMBiologics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding IMBiologics
Sign Up For FreeTo access detailed company insights
IMBiologics is an innovative biopharmaceutical company established in August 2020, specializing in the development of antibody-based therapeutics for autoimmune diseases and immuno-oncology. Utilizing their proprietary antibody modality technology, IM-OpDECon, the company aims to address unmet medical needs in the field of immunomodulatory biologic... Read More
